TherapeuticsMD reported $-1.64M in EBITDA for its fiscal quarter ending in September of 2023.





Ebitda Change Date
AbbVie USD 5.37B 1.85B Dec/2025
Alterity Therapeutics Limited AUD -7.72M 2.99M Jun/2023
Cipla INR 14.03B 4.48B Jun/2026
Clal Biotechnology ILS -5.3M 2.09M Dec/2022
Compugen USD -9.02M 1.12M Mar/2026
CSL USD 3.13B 1.17B Dec/2025
Grifols EUR 482.04M 7.04M Sep/2025
Novo Nordisk DKK 31.44B 6.84B Sep/2025
Pfizer USD 5.99B 5.23B Mar/2026
TherapeuticsMD USD -1.64M 700K Sep/2023